134 related articles for article (PubMed ID: 28674712)
1. Expression of sex-determining region Y-box protein 2 in breast cancer and its clinical significance.
Feng X; Lu M
Saudi Med J; 2017 Jul; 38(7):685-690. PubMed ID: 28674712
[TBL] [Abstract][Full Text] [Related]
2. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.
Lengerke C; Fehm T; Kurth R; Neubauer H; Scheble V; Müller F; Schneider F; Petersen K; Wallwiener D; Kanz L; Fend F; Perner S; Bareiss PM; Staebler A
BMC Cancer; 2011 Jan; 11():42. PubMed ID: 21276239
[TBL] [Abstract][Full Text] [Related]
3. Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases.
Huang YH; Luo MH; Ni YB; Tsang JY; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
Histopathology; 2014 Mar; 64(4):494-503. PubMed ID: 24382260
[TBL] [Abstract][Full Text] [Related]
4. High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity.
Züllig L; Roessle M; Weber C; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H; Huber GF
Eur J Cancer; 2013 May; 49(8):1915-22. PubMed ID: 23414798
[TBL] [Abstract][Full Text] [Related]
5. Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity.
Wu F; Zhang J; Wang P; Ye X; Jung K; Bone KM; Pearson JD; Ingham RJ; McMullen TP; Ma Y; Lai R
Cell Signal; 2012 Nov; 24(11):1989-98. PubMed ID: 22800865
[TBL] [Abstract][Full Text] [Related]
6. High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.
Chuang WY; Chang YS; Chao YK; Yeh CJ; Liu YH; Tseng CK; Chang HK; Wan YL; Hsueh C
Int J Clin Exp Pathol; 2015; 8(8):9248-55. PubMed ID: 26464673
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion.
Wang Y; Zhou J; Wang Z; Wang P; Li S
Biochem Biophys Res Commun; 2017 Nov; 493(1):429-436. PubMed ID: 28882595
[TBL] [Abstract][Full Text] [Related]
8. Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells.
Yang N; Wang Y; Hui L; Li X; Jiang X
J Histochem Cytochem; 2015 Sep; 63(9):721-33. PubMed ID: 26001828
[TBL] [Abstract][Full Text] [Related]
9. SOX2 gene expression and its role in triple negative breast cancer tissues.
Yao GD; Niu YY; Chen KX; Meng HX; Yao GD; Song HT; Tian ZN; Geng JS; Feng MY
J Biol Regul Homeost Agents; 2018; 32(6):1399-1406. PubMed ID: 30574744
[TBL] [Abstract][Full Text] [Related]
10. NONO Is a Negative Regulator of
Liang S; Takahashi H; Hirose T; Kuramitsu Y; Hatakeyama S; Yoshiyama H; Wang R; Hamada JI; Iizasa H
Cancer Genomics Proteomics; 2020; 17(4):359-367. PubMed ID: 32576581
[TBL] [Abstract][Full Text] [Related]
11. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
[TBL] [Abstract][Full Text] [Related]
12. Expression and Clinical Significance of Ki67 and SOX2 in Colorectal Cancer.
Hu B; Song X; Ding W; Wang H; Cai H; Huang Z
J Healthc Eng; 2023; 2023():3783631. PubMed ID: 37457497
[TBL] [Abstract][Full Text] [Related]
13. Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.
Schröck A; Göke F; Wagner P; Bode M; Franzen A; Braun M; Huss S; Agaimy A; Ihrler S; Menon R; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
PLoS One; 2013; 8(3):e59201. PubMed ID: 23544055
[TBL] [Abstract][Full Text] [Related]
14. SOX2 autoantibodies as noninvasive serum biomarker for breast carcinoma.
Sun Y; Zhang R; Wang M; Zhang Y; Qi J; Li J
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2043-7. PubMed ID: 22832207
[TBL] [Abstract][Full Text] [Related]
15. Expression of Sox2 in breast cancer cells promotes the recruitment of M2 macrophages to tumor microenvironment.
Mou W; Xu Y; Ye Y; Chen S; Li X; Gong K; Liu Y; Chen Y; Li X; Tian Y; Xiang R; Li N
Cancer Lett; 2015 Mar; 358(2):115-123. PubMed ID: 25444903
[TBL] [Abstract][Full Text] [Related]
16. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
17. SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis.
Russo MV; Esposito S; Tupone MG; Manzoli L; Airoldi I; Pompa P; Cindolo L; Schips L; Sorrentino C; Di Carlo E
Oncotarget; 2016 Mar; 7(11):12372-85. PubMed ID: 26540632
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of human breast cancer cells with SOX2 promoter activity.
Liang S; Furuhashi M; Nakane R; Nakazawa S; Goudarzi H; Hamada J; Iizasa H
Biochem Biophys Res Commun; 2013 Jul; 437(2):205-11. PubMed ID: 23796710
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic implications of EpCAM and Sox2 expression in breast cancer.
Abd El-Maqsoud NM; Abd El-Rehim DM
Clin Breast Cancer; 2014 Feb; 14(1):e1-9. PubMed ID: 24201161
[TBL] [Abstract][Full Text] [Related]
20. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
Peng L; Li FX; Shao WF; Xiong JB
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]